Skip to main content
. 2012 Jun 29;7(6):e40110. doi: 10.1371/journal.pone.0040110

Table 4. Effect of aprotinin on hemodynamics and LV remodeling at 2 day and 4 wk rats.

2 day 4 wk
Sham(n = 5) ACF(n = 5) Sham+Apr(n = 5) ACF+Apr(n = 5) Sham(n = 7) ACF(n = 8) Sham+Apr(n = 7) ACF+Apr(n = 8)
HR (beats/min) 359±6 367±8 371±4 375±12 321±7 307±3 312±5 316±3
MAP (mmHg) 100±2 89±3 106±1 84±5* 107±3 90±2* 106±5 86±2*
LVEDP (mmHg) 6±1 11±1 5±1 11±2* 4±0 10±1* 4±1 10±1*
LVESP (mmHg) 55±3 61±3 58±2 57±4 85±3 75±2 86±5 70±3*
LV+dP/dt (mmHg/s) 8767±391 9386±260 8301±442 9065±354 8505±450 8116±348 7931±415 8937±423
LV-dP/dt (mmHg/s) −7474±152 −8797±411 −8474±123 −7879±530 −7379±445 −5948±131* −7422±236 −6834±333
LVEDD (mm) 6.9±0.2 8.2±0.2* 7.0±0.1 8.0±0.1* 7.7±0.2 10.6±0.3* 7.6±0.1 10.2±0.2*
LVESD (mm) 4.0±0.2 4.3±0.5 4.1±0.2 4.0±0.2 4.7±0.2 6.8±0.3* 4.7±0.2 5.9±0.2*
LVEDD/PW 4.6±0.2 5.8±0.2* 4.6±0.3 5.4±0.4 4.2±0.2 5.7±0.3* 4.5±0.4 6.0±0.4*
LV FS (%) 41±2 48±5 43±2 50±3 38±2 37±1 39±1 43±1
LV EF (%) 66±3 76±5 72±2 79±3 66±2 63±2 67±2 71±1
VCFr (%) 8.3±0.6 10.2±0.5 9.8±0.8 10.1±0.6 7.9±0.8 5.7±0.2 7.5±0.5 7.4±0.6
LVED-WS (g/cm2) 4±1 16±1* 6±1 16±4* 4±1 15±2* 4±1 16±2*
LVES-WS (g/cm2) 50±3 54±3 49±9 37±7 65±5 81±8 68±8 62±6
Coll Vol (%) 3.9±0.2 2.1±0.1* 4.0±0.3 3.6±0.2 3.5±0.1 2.4±0.1* 3.5±0.1 3.2±0.1

Values are expressed as mean±SEM. In each group, values in parentheses represent n. *P<0.05 vs. age-matched shams. P<0.05 vs. ACF. ACF: aortocaval fistula; Apr: aprotinin; HR: heart rate; MAP: mean arterial pressure; LVEDP: LV end-diastolic pressure; LV+dP/dt: LV pressure derivative maximum; LV-dP/dt: LV pressure derivative minimum. LVEDD: LV end-diastolic dimension; LVESD: LV end-systolic dimension; LVEDD/PW: LV end-diastolic dimension to posterior wall thickness ratio; FS: fractional shortening; EF: ejection fraction; VCFr: velocity of circumferential fiber shortening; LVED-WS: LV end-diastolic wall stress; LVES-WS: LV end-systolic wall stress; Coll Vol (%): interstitial collagen volume percent.